GlassScriptPhysician profile
Dennis W Oconnor
NPI 1912935743
$3,361.78
in general payments reported to CMS, 2019-2025
30 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $306 · 2021: $457 · 2022: $525 · 2023: $723 · 2024: $449 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,757.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.58 | 2019-2025 | |
| Lilly USA, LLC | $344.51 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $343.70 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $320.73 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $304.69 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.86 | 2019-2025 | Spiriva Respimat, Jardiance, Stiolto Respimat |
| Janssen Pharmaceuticals, INC | $178.96 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $153.45 | 2019-2025 | Gardasil 9, Capvaxive, Verquvo |
| Abbott Laboratories | $115.38 | 2022-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Exact Sciences Corporation | $99.80 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $96.04 | 2019-2023 | |
| Glaxosmithkline, LLC. | $89.82 | 2019-2025 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $85.15 | 2019-2025 | Uzedy, Austedo Xr |
| Astellas Pharma US INC | $59.00 | 2019-2023 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.37 | 2023-2025 | Caplyta |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $51.93 | 2023 | Korlym |
| Supernus Pharmaceuticals, INC. | $44.98 | 2025 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $39.16 | 2022 | |
| Amarin Pharma, INC. | $37.14 | 2019-2020 | |
| Inogen, INC. | $34.09 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Nabriva Therapeutics, Plc | $33.84 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $31.76 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.18 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $23.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.59 | 2024 | Eliquis |
| Phathom Pharmaceuticals, INC. | $20.66 | 2024 | Voquezna |
| Neurocrine Biosciences, INC. | $20.38 | 2025 | |
| Xeris Pharmaceuticals, INC. | $14.65 | 2024 | Gvoke Hypopen |
| Esperion Therapeutics, INC. | $12.07 | 2021 | |
| Advanced Oxygen Therapy INC. | $9.68 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.